Skip to main content
MOA Life Plus Co. Ltd. logo

MOA Life Plus Co. Ltd. — Investor Relations & Filings

Ticker · 142760 ISIN · KR7142760008 KO Manufacturing
Open in API
Filings indexed 361 across all filing types
Latest filing 2021-11-29 Capital/Financing Update
Country KR South Korea
Listing KO 142760

About MOA Life Plus Co. Ltd.

http://moalifeplus.com/

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Recent filings

Filing Released Lang Actions
주요사항보고서(교환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the issuance of exchangeable bonds (교환사채권 발행결정). It details the terms of the financing, including interest rates, put/call options, and the use of proceeds. This falls under the category of capital and financing updates as it describes a specific corporate fundraising activity.
2021-11-29 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission and Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, including interest rates, maturity, conversion price, and the use of proceeds. This falls under the category of capital and financing updates.
2021-11-29 Korean
주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the decision to transfer shares of another corporation (타법인 주식 및 출자증권 양도결정). This is a specific regulatory disclosure required for material corporate events. Since it details a specific transaction involving the transfer of assets/shares and does not fit into categories like M&A (which usually implies a merger or acquisition of the company itself) or Share Issue, it is best classified as a Regulatory Filing (RNS) as it serves as a formal regulatory announcement of a material event.
2021-11-29 Korean
[기재정정]분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Bioleaders Corporation' (주)바이오리더스 for the 3rd quarter of the 22nd fiscal year. It contains detailed financial statements, management discussions, and corporate information. Although it is labeled as a 'Correction Report' (정정신고), it is a comprehensive financial filing that includes the full quarterly report content. Therefore, it is classified as an Interim/Quarterly Report. 9M 2021
2021-11-16 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the 3rd quarter of the 22nd fiscal year for Bioleaders Corporation. It contains detailed financial information, business descriptions, and corporate governance data, which is characteristic of a formal quarterly financial filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). 9M 2021
2021-11-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership and collateral agreements by a major shareholder (Park Young Chul) of BioLeaders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and related contractual changes.
2021-09-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.